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Background: During cerebral cortical development, neural precursor-precursor interactions in the ventricular zone
neurogenic niche coordinate signaling pathways that regulate proliferation and differentiation. Previous studies
with shRNA knockdown approaches indicated that N-cadherin adhesion between cortical precursors regulates
β-catenin signaling, but the underlying mechanisms remained poorly understood.
Results: Here, with conditional knockout approaches, we find further supporting evidence that N-cadherin
maintains β-catenin signaling during cortical development. Using shRNA to N-cadherin and dominant negative
N-cadherin overexpression in cell culture, we find that N-cadherin regulates Wnt-stimulated β-catenin signaling in a
cell-autonomous fashion. Knockdown or inhibition of N-cadherin with function-blocking antibodies leads to
reduced activation of the Wnt co-receptor LRP6. We also find that N-cadherin regulates β-catenin via AKT, as
reduction of N-cadherin causes decreased AKT activation and reduced phosphorylation of AKT targets GSK3β and
β-catenin. Inhibition of AKT signaling in neural precursors in vivo leads to reduced β-catenin-dependent
transcriptional activation, increased migration from the ventricular zone, premature neuronal differentiation, and
increased apoptotic cell death.
Conclusions: These results show that N-cadherin regulates β-catenin signaling through both Wnt and AKT, and
suggest a previously unrecognized role for AKT in neuronal differentiation and cell survival during cortical development.
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In the developing cerebral cortex, neural precursors reside
in the ventricular zone (VZ), a neurogenic zone of neuro-
epithelial cells that lines the lateral ventricles. The special-
ized microenvironment or niche within the VZ coordinates
signaling pathways that regulate the self-renewal and differ-
entiation of neural precursors. Recent studies suggest that
the adherens junctions and apical domains of neural pre-
cursors contain signaling molecules that regulate interac-
tions between neural precursors critical in maintaining
precursor identity [1,2]. Knockdown of the adherens junc-
tion proteins N-cadherin [3] or αE-catenin [4] in cortical
VZ cells caused reduced β-catenin signaling, increased exit
from the cell cycle, premature neuronal differentiation, and* Correspondence: achenn@uic.edu
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reproduction in any medium, provided the orincreased migration out of the VZ. Although these findings
suggest a novel role for N-cadherin-containing junctions in
the positive regulation of β-catenin signaling during cortical
development, little is known about the molecular mecha-
nisms by which N-cadherin maintains β-catenin signaling.
Recent studies suggest that one way N-cadherin adhe-
sion can influence β-catenin signaling is through regulat-
ing the AKT signaling pathway. AKT signaling impacts
many fundamental processes regulating growth and me-
tabolism; in organ development, AKT functions in the
regulation of normal organ size by mediating signaling
downstream of insulin and insulin-like growth factor I
[5]. In mammals, the AKT family is comprised of three
highly conserved members, AKT1, AKT2, and AKT3.
While AKT1−/− mice display a general reduction in sizes
of all organs [6], AKT3−/− mice have a selective decreaseLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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AKT1 nor AKT3 mutant mice showed abnormalities in
insulin signaling [7], suggesting that brain size regulation
by AKT was mediated through alternative non-insulin
signaling mechanisms. Recently, findings of active mu-
tations of AKT3 in patients with hemimegalencephaly
(HMG), an overgrowth of one hemisphere during brain
development, provided further support for the role of
AKT signaling in human brain size regulation [8-10].
N-cadherin adhesion can lead to phosphatidylinositol
3-kinase (PI3K)-mediated activation of AKT [11], and
activated AKT signaling can stimulate β-catenin signaling.
In intestinal stem cells (ISCs), loss of PTEN (phosphatase
and tensin homolog), a negative regulator of PI3K/AKT,
leads to β-catenin stabilization and upregulated β-catenin
signaling [12]. In ISCs the mechanism by which AKT acti-
vates β-catenin signaling is via direct phosphorylation of β-
catenin at residue Serine 552, which primes β-catenin for
14-3-3ζ binding and stabilization [13]. Moreover, AKT also
phosphorylates and inactivates glycogen synthase kinase
(GSK)3β at Serine 9; as GSK3β functions as a negative
regulator of β-catenin stabilization, AKT phosphorylation
of GSK3β can lead to β-catenin stabilization and nuclear β-
catenin accumulation [14]. Our previous work suggested
that N-cadherin engagement also activates β-catenin signal-
ing through AKT in cortical precursors [3]. While AKT ac-
tivity was recently described in dividing mouse developing
neural precursors [8], how AKT signaling is regulated dur-
ing neural development, and the underlying mechanisms
through which AKT mediates brain growth, remains poorly
understood.
The current study seeks to provide greater understanding
of the mechanistic relationships between N-cadherin and
β-catenin signaling in cortical development, using a com-
bination of in vivo and cell culture approaches. Here we
find further supporting in-vivo data that N-cadherin func-
tions in the cortical VZ to maintain β-catenin signaling. We
also find evidence using in vivo electroporation approaches
and cell co-culture experiments for a cell-autonomous N-
cadherin role in receiving Wnt signaling. In addition to its
role in transducing Wnt signals through the Wnt co-
receptor LRP6, we find that N-cadherin also regulates AKT
phosphorylation and activation. Knockdown of N-cadherin
leads to reduction of AKT phosphorylation as well as a re-
duction of Serine 552 phosphorylated β-catenin and Serine
9 phosphorylated GSK3β, both direct targets of active AKT.
We show that both β-catenin Ser-552-P and GSK3β
Ser-9-P are expressed in mitotic radial glial progenitor cells
in the developing cortex, suggestive of activation of AKT
signaling in these cells. Using in utero electroporation, we
show that inhibition of AKT signaling using a dominant
negative AKT (DN-AKT) leads to premature exit from
the VZ, increased neuronal differentiation, and increased
apoptotic cell death. Together, these studies suggest apathway linking N-cadherin cell adhesion to the regulation
of cell survival and differentiation via AKTactivation.
Results
N-cadherin maintains β-catenin signaling in cortical
precursors in vivo
During cortical development, β-catenin signaling is active
in neural precursors within the VZ [15] and regulates
neural precursor proliferation [15,16] and differentiation
[17]. Our previous studies suggested that N-cadherin, the
primary cadherin of adherens junctions in cortical precur-
sors [18], maintains β-catenin signaling and prevents
neural precursors from premature differentiation [3].
Electroporation of N-cadherin-shRNA (Ncad-shRNA) in
VZ precursors in vivo reduced the expression of an opti-
mized β-catenin signaling reporter, TOPdGFP [3].
To confirm the role of N-cadherin in β-catenin signaling
in embryonic brains using a genetic conditional knockout
approach, we crossed (1) Axin2-d2EGFP mice, which re-
ports endogenous β-catenin signaling by a destabilized
EGFP under the control of the endogenous Axin2 pro-
moter/enhancer regions [19,20], with (2) NcadFlox/Flox
mice, in which the first exon of the N-cadherin gene
containing the translational start site and upstream tran-
scriptional regulatory sequences are flanked by loxP se-
quences [21], and (3) Nes11Cre mice, which exhibit
widespread Cre recombinase expression in neural pro-
genitor cells by E11 [22]. Staining for d2EGFP in E12.0
Ncad cKO brain (Axin2-d2EGFP; Nes11Cre; NcadFlox/Flox)
embryonic cortex and littermate control (Axin2-d2EGFP;
Nes11Cre; NcadFlox/+) revealed that conditional tissue-
wide knockout of N-cadherin reduced EGFP expression in
the developing VZ (Figure 1A).
To examine the cell-autonomous role of N-cadherin in
β-catenin signaling in VZ precursors, we co-electroporated
expression plasmids for Cre recombinase and TOPdGFP
[23] into the VZ of E13.5 NcadFlox/Flox embryos. This ap-
proach enables conditional deletion of genes from cells re-
ceiving the Cre plasmid [4,15,24] and, as the reporter GFP
is produced by the simultaneously introduced plasmids,
the signaling readout is not affected by historical activation
of the signaling pathway. Staining for GFP 24 hours after
electroporation showed that, compared to cells electro-
porated with the pcDNA-lacZ control, Cre electroporation
reduced β-catenin signaling (Figure 1B). Together, these re-
sults support our previous finding that cell-autonomous
N-cadherin is required for maintenance of β-catenin sig-
naling in cortical neural progenitor cells.
N-cadherin functions in Wnt-induced β-catenin signaling
in 293 T cells in a cell-autonomous manner
We observed previously that N-cadherin adhesion regu-
lated endogenous β-catenin signaling activity in neural
precursors [3]. The most well-characterized and common
Figure 1 Conditional knockout of N-cadherin reduces β-catenin signaling in developing cortical precursors. (A) Immunostaining for
d2EGFP (green) in E12.0 littermate control (Axin2-d2EGFP; Nes11Cre; NcadFlox/+) and Ncad cKO brain (Axin2-d2EGFP; Nes11Cre; NcadFlox/Flox)
embryonic cortex reveals that conditional tissue-wide knockout of N-cadherin leads to reduced EGFP expression in the developing ventricular
zone (VZ) (DNA stained with DAPI, pseudocolored blue; bar = 100 μm). (B) Focal elimination of N-cadherin reduces β-catenin transcriptional
activity. β-catenin mediated transcriptional activation was examined through expression of destabilized GFP controlled by the TOP promoter.
E13.5 embryos were electroporated with pTOP-dGFP, pCAG-mCherry, and pCAGLacZ in the control treatment, and with pTOP-dGFP, pCAG-
mCherry, and pCAG-Cre in the experimental condition, and analyzed at E14.5. The dot image below shows the positions of the individual
electroporated cells (yellow dots represent double-labeled mCherry/dGFP + cells and red dots represent dGFP- cells (expressing mCherry only)).
Only electroporated cells in the VZ were included in the analysis, and the proportion of cells expressing dGFP was compared to the total number
of electroporated cells in the VZ. *P = 0.0242 by unpaired Student’s t-test, n = 3 brains for each. Error bars represent 1 SEM. Bar = 50 μm.
EP’d, electroporated.
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Wnt proteins. Wnt signaling results in inactivation of
a phosphodestruction complex that normally serves to
target free cytosolic β-catenin for ubiquitin-mediated deg-
radation [25]. Our previous observations that increasing
neural precursor cell density could increase β-catenin
transcriptional activation [3] activity suggested that cell
proximity/density could regulate Wnt/β-catenin signaling.To examine further the relationship of cell proximity
and Wnt/β-catenin signaling, we created signaler (Wnt
“signaler”) and reporter (Wnt “reporter”) cells (that re-
port activation of β-catenin-mediated transcription) by
transfecting separate populations of 293 T cells with
Wnt3a expression and pSuper8xTOPFlash reporter con-
structs and examined signaling in cells plated either on
the opposite of a polycarbonate transwell filter (“short
Figure 2 (See legend on next page.)
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Figure 2 N-cadherin functions in Wnt-induced β-catenin signaling in a cell-autonomous manner. (A) Separate populations of 293 T cells
were transfected with Wnt3a expression and pSuper8TOPFlash reporter constructs and plated either on the opposite of a polycarbonate transwell
filter (“membrane bound”) or on the bottom of the transwell assay (“separated”). In a TOPFlash reporter assay, Wnt3a-expressing signaler cells
induced β-catenin signaling in reporter cells adherent on the opposite face of the transwell membrane, but not in reporter cells plated separately
at the bottom of the chamber. P = 0.004 by repeated measures analysis of variance (ANOVA), ***P < 0.001, Neuman Keuls post-hoc test, n = 3.
(B) Reduction of N-cadherin by shRNA (Ncad-shRNA) or by overexpression of C-terminal truncated N-cadherin (NcadΔC) in Wnt-responsive cell
results in reduced Wnt-activated β-catenin transcriptional activation. Wnt3a transfected signaler cells were co-cultured with pTOPflash-transfected
reporter cells co-transfected with either shRNA to N-cadherin (P = 0.0012 by repeated measures ANOVA, **P < 0.01, *P < 0.05 by Neuman Keuls
post-hoc test; n = 4) or NcadΔC (P = 0.0006 by repeated measures ANOVA, ***P < 0.001, **P < 0.01 by Neuman Keuls post-hoc test; n = 3), and
luciferase activity was measured 24 hours after co-culture. (C) Inhibition of N-cadherin in the Wnt-producing signaling cell does not affect
Wnt-mediated β-catenin signaling. Wnt3a transfected signaler cells were co-transfected with either Ncad-shRNA (P = 0.0024 by repeated measures
ANOVA, **P < 0.01 by Neuman Keuls post hoc test; n = 4) or NcadΔC (P = 0.0002 by repeated measures ANOVA, ***P < 0.001 by Neuman Keuls
post-hoc test; n = 3), co-cultured with pTOPflash-transfected reporter cells, and luciferase activity was measured 24 hours after co-culture.
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(“long-distance”) (Figure 2A). When plated on opposite
sides of the filter, cells can make physical contacts with
the cells on the opposite side through the 0.4 μm pores
[26,27]. We found that Wnt3a-expressing signaler cells
induced β-catenin signaling in reporter cells adherent on
the opposite face of the transwell membrane, but not in
reporter cells plated separately at the bottom of the cham-
ber (Figure 2A). Together with our previous findings that
N-cadherin mediates density-dependent β-catenin signal-
ing, this observation that Wnt induction of β-catenin sig-
naling requires close cell-cell apposition suggested a role
for N-cadherin cell adhesion in mediating Wnt signaling.
To examine specifically the role of N-cadherin in Wnt
signaling, we conducted loss-of-function studies of N-
cadherin in either signaler or reporter cells. Transfection
of Ncad-shRNA or dominant negative N-cadherin with
a C-terminal β-catenin binding domain truncation (N-
cadΔC) in reporter cells reduced Wnt-induced β-catenin
signaling in a cell-autonomous fashion (Figure 2B). In
contrast, N-cadherin knockdown or expression of N-cad
ΔC in signaler cells resulted in a trend towards reduced
Wnt-induced β-catenin signaling (Figure 2C), suggesting
only a modest role for non-cell-autonomous function for
N-cadherin in Wnt signaling. Together, the in vivo electro-
poration and co-culture findings suggest that N-cadherin
maintains Wnt-induced β-catenin signaling through a cell-
autonomous mechanism. These co-culture findings also
suggest a role for non-autonomous N-cadherin in Wnt
signaling, likely mediated in part by the requirement for
close cell apposition.
Reduction of N-cadherin leads to reduction of AKT and
LRP6 phosphorylation
Recent studies have suggested that cadherin adhesion can
both positively [28] and negatively [25] regulate β-catenin
signaling in a Wnt-independent manner. To explore fur-
ther the downstream pathways linking cell-autonomous
N-cadherin function to β-catenin signaling, we examinedtargets of Wnt-independent and Wnt-stimulated activa-
tion of β-catenin following knockdown or blockade of N-
cadherin in cultured cells.
To examine the role of N-cadherin in regulation of β-
catenin in the absence of Wnt stimulation, we transfected
293 T cells with N-cadherin-shRNA or EGFP-shRNA con-
trol. Western blot analysis after 24 hours incubation
showed that, in the absence of exogenous Wnt, Ncad-
shRNA reduced active AKT (phospho-AKT Ser 473). We
also found reductions in two direct downstream targets
of active AKT - GSK3β phosphorylated at Serine 9, and β-
catenin phosphorylated at Serine 552 - following N-
cadherin-shRNA transfection (Figure 3A). Phosphorylation
of β-catenin at Ser 552 increases its transactivation by in-
creasing its stability [13], while phosphorylation of GSK3β
leads to inactivation of the GSK3β and can result in ac-
cumulation of β-catenin [14]. We also observed a trend
where Ncad-shRNA reduced total β-catenin levels, consis-
tent with prior observations that phosphorylation at Ser
552 increasing β-catenin stability [13].
In 293T cell lines stably expressing Ncad-shRNA, we
observed similar findings: reduction of N-cadherin ex-
pression led to reduced levels of active AKT (phosphor-
Ser 473), GSK3β phospho-Ser 9, and β-catenin phosph-
Ser 552 in the absence of Wnt (Figure 3B). Together,
these findings suggest that, in the absence of Wnt, N-
cadherin can regulate AKT activity and β-catenin levels
via phosphorylation of β-catenin at Ser 552.
In the absence of exogenous Wnt, we also observed
in the stable N-cadherin knockdown lines that levels
of phosphorylated LRP6, the Wnt co-receptor, were
also reduced (Figure 3B). As phosphorylation of LRP6
results from activation by Wnt [29], together with the
observations that Wnt stimulation of signaling required
N-cadherin (Figure 2), this finding suggested that Wnt-
stimulated β-catenin signaling via LRP6 is impacted by
N-cadherin levels. When the stable N-cadherin knock-
down cell lines were transfected with Wnt3a to activate
the Wnt signaling pathway, we observed increased
Figure 3 Reduction of N-cadherin leads to reduction of AKT and LRP6 phosphorylation. (A) Transfection of N-cadherin-shRNA
(Ncad-shRNA) reduced the amount of AKT phosphorylated at Serine 473 (P-AKT [S473P]) and AKT targets β-catenin phospho-Serine 552, β-catenin
[S552-P]) and phosphorylated GSK3β (P-GSK3β [Ser 9]). N-cadherin, P = 0.0151 by paired t-test, n = 7; P-AKT [S473], P = 0.0182 by paired t-test,
n = 6; P-β-catenin [S552], P = 0.0083 by paired t-test, n = 3; P-GSK3β [Ser 9], P = 0.0085 by paired t-test, n = 3. Consistent with the stabilizing role of
phosphorylated Ser 552, there was a trend for reduction in total β-catenin in N-cad-shRNA transfected cells (P = 0.1383 by paired t-test, n = 2).
(B) Cells stably expressing N-cad-shRNA knockdown reveal reduced levels of AKT phosphorylation (P-AKT [S473], phospho-GSK3β (P-GSK3β [S9]),
and phospho-β-catenin (P-β-catenin [S552]). N-cadherin knockdown also reduced baseline phosphorylation of LRP-6 (P-LRP6 [S1490]) as well as
Wnt3a-induced phosphorylation of LRP6. (C) Primary mouse cortical progenitors were nucleofected with two different shRNA to N-cadherin or
EGFP and cell extracts were blotted for phospho-β-catenin Serine 552 (P-β-catenin [S552]). In both cases, N-cadherin knockdown resulted in
reduced phosphorylation of β-catenin at Ser 552. shRNA1: P = 0.0119 by paired t-test (n = 3); shRNA2: P = 0.0055 by paired t-test (n = 3).
(D) Primary mouse neural stem cells derived from E14.5 mouse cortices were treated for 24 hours with either control IgG or N-cadherin function
blocking antibody 20 μg/ml, and cell extracts were blotted for phospho-LRP6 [S1490]. Both biological replicates are shown.
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that, in N-cadherin knockdown cells, Wnt3a-induced
phosphorylation of LRP6 was also reduced. Together,
these findings suggest that N-cadherin levels also regu-
late Wnt-induced phosphorylation of its co-receptor
LRP6.
To examine the role of N-cadherin in Ser 552 phos-
phorylation of β-catenin in cortical neural stem cells
(NSC), we utilized mouse cortical NSC derived from
E14.5 mouse cortices [30,31]. Using two different shRNA
constructs against N-cadherin (pSRNcad (“shRNA1”)
and pSM2cNcad (“shRNA2”)), we found that reductionin N-cadherin caused a reduction in the amount of
β-catenin phosphorylated at Ser 552 (Figure 3C). To
examine the role of N-cadherin in the phosphorylation
and activation of the Wnt co-receptor LRP6 in NSC, we
treated the NSC with either IgG control antibody or
N-cadherin function-blocking antibodies (GC-4, Sigma;
St. Louis, USA) and examined levels of phosphorylated
LRP6 (Figure 3D). We found that inhibition of N-
cadherin dramatically reduced the levels of phospho-
LRP6 in primary cortical NSC, providing further support
for the notion that N-cadherin also functions in
β-catenin signaling in neural stem/progenitors by
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and LRP6-mediated Wnt signaling.
Targets of AKT activity are expressed in dividing radial
glia during cortical development
These findings that N-cadherin functions in Ser 55
phosphorylation of β-catenin in cortical NSC suggest
that AKT signaling may play an important role in
cerebral cortical development. A recent study pointed
to somatic activating mutations in AKT3 that caused
HMG and highlighted the presence of phosphorylated
AKT (P-Ser-473) in dividing cortical neural precursors
suggestive of active AKT signaling [8]. To examine
downstream targets of AKT signaling in the developing
cortex, we examined the expression of GSK3β-Ser 9-P
and β-catenin Ser 552-P in VZ precursors. We ob-
served widespread localization of GSK3β Ser 9P and
β-catenin Ser 552P in dividing apical neural progeni-
tors in the VZ. P-GSK3β and P-β-catenin co-localized
with the radial glial marker phospho-Vimentin 4A4
[8,32] (Figure 4). 74.3 ± 5.9% (1 SEM) of P-Vim ex-
pressing cells were also expressing P-β-catenin, and 82.5
± 3.6% (1 SEM) of P-Vim-expressing cells were also P-
GSK3β positive. While GSK3β Ser 9 and β-catenin Ser 552
have been shown to be direct targets of AKT signaling
[12], our data do not rule out other kinases that might
phosphorylate these residues (e.g. protein kinase C (PKC)
and GSK3β Ser 9 [33], PKA and β-catenin Ser-552 [34]).
However, together with the observations of active AKT in
these same cells, our findings provide further support forFigure 4 Targets of AKT activity are expressed in dividing
radial glia during cortical development.
Immunohistofluorescence staining of cortical sections at embryonic
day 12.5 reveals AKT activity as assessed by targets of AKT phospho-
β-catenin [S552] and phosphor-GSK3β [S9] in the ventricular zone
(VZ). (A) Phospho-beta-catenin-Ser 552 (pseudocolored red) is
expressed in dividing radial glial cortical precursors identified by the
expression of phosphorylated vimentin 4A4 (P-vim, pseudocolored
green) located at the apical (lumenal) surface of the VZ. (B) Phospho-
GSK3beta-Ser 9 (pseudocolored red) is expressed in dividing radial glial
cortical precursors expressing phosphorylated vimentin 4A4 (P-vim,
pseudocolored green) at the apical ventricular surface. Scale bar = 20
μm. 74.3 ± 5.9% (1 SEM) of P-Vim expressing cells were also expressing
P-β-catenin (n = 3 brains), and 82.5 ± 3.6% (1 SEM) of P-Vim-expressing
cells were also P-GSK3β positive (n = 3 brains).active AKT signaling in radial glial precursors in the devel-
oping cortex.
AKT maintains β-catenin signaling and neural
differentiation in vivo
To examine directly whether AKT regulates β-catenin
signaling in cortical progenitors in vivo, we inhibited
AKT signaling by in utero electroporation of a kinase-
dead dominant negative AKT (DN-AKT) and examined
β-catenin signaling using a co-electroporated β-catenin
signaling reporter, TOPdGFP. We found that DN-AKT
reduced β-catenin signaling in cortical VZ cells, sug-
gesting that AKT is required for maintaining β-catenin
signaling during cortical development (Figure 5). As β-
catenin signaling is both necessary and sufficient to drive
cortical precursor self-renewal, we next sought to exam-
ine whether modulating AKT signaling influenced pre-
cursor identity.
AKT signaling regulates normal organ size during
development: AKT1−/− mice display a general reduc-
tion in sizes of all organs [6]; AKT3−/− mice present
a selective decrease in brain size [7]; and three recent
studies suggest that mutations and overactivation of
AKT3 can cause enlargement of the brain in cases of
human HMG [8-10]. Consistent with the idea that AKT
activity regulates neural precursor proliferation, retroviral
overexpression of AKT1 promoted retention of cortical
progenitors in the VZ and subventricular zone and in-
creased NSC self-renewal [35]. After in utero electropor-
ation of DN-AKT, we observed increased cell exit from
the VZ towards the pial surface and premature neuronal
differentiation (Figure 6). AKT signaling may also function
in maintaining cell adhesion, as inhibition by DN-AKT de-
creases the fraction of cells in contact with the ventricle
(Figure 6G).
AKT signaling normally impacts a broad range of cel-
lular processes including apoptotic cell death. Many
members of the apoptotic signaling cascade are targets
of AKT-mediated phosphorylation and inactivation [36],
and GSK3β inhibition by AKT has been shown to pro-
tect both neurons [37] and neural precursor cells from
apoptosis [38]. To examine whether inhibition of AKT
signaling in the developing cortex alters cell apoptosis,
we co-stained in utero electroporated cortices for the
apoptotic marker cleaved caspase 3. We found that com-
pared with control GFP-electroporated cells, where only
~1% of electroporated cells were apoptotic, a much lar-
ger fraction of cells that received DN-AKT (~15%) ex-
hibited signs of apoptosis (cleaved caspase 3 expression,
condensed nucleus by DAPI) (Figure 7). These findings
suggest that a critical role of AKT signaling in cortical
development is in maintenance of cell survival during
the neurogenic period. Further study is required to de-
termine whether different threshold levels of AKT
Figure 5 Inhibition of AKT signaling reduces β-catenin transcriptional activity in vivo. β-catenin mediated transcriptional activation was
examined through expression of destabilized GFP controlled by the TOP promoter. E13.5 embryos were electroporated with pTOP-dGFP, pCAG-
mCherry, and pcDNA in the control treatment, and with pTOP-dGFP, pCAG-mCherry, and dominant negative AKT (DN-AKT) in the experimental
condition and analyzed 30 hours after electroporation. The dot image below shows the positions of the electroporated cells (green dots
represent electroporated cells co-expressing dGFP and mCherry, and red dots represent dGFP- cells (expressing mCherry only)). Only
electroporated cells in the ventricular zone (VZ) were included in the analysis, and the proportion of cells expressing dGFP was compared to the
total number of electroporated cells (red, labeled by mCherry) in the VZ. Compared to pcDNA control, DN-AKT expression reduced the fraction of
TOPdGFP-expressing cells from 73 to 53% (n = 3 brains each), **P = 0.0043 by unpaired t-test. Error bars represent 1 SEM. Scale bar = 100 μm.
EP’d, electroporated.
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sus undergo programmed cell death in cortical
development.Discussion
A growing body of work points to a critical role for
adherens junctions in maintaining neural progenitor
identity [39], and a recent study provided evidence that
regulation of N-cadherin expression by Foxp2 and Foxp4
initiates neuronal delamination from the VZ and differ-
entiation [40]. Here we expand our understanding of the
molecular mechanisms through which N-cadherin regu-
lates the neural precursor niche in cerebral cortical devel-
opment. Our observations suggest that cell-autonomous
N-cadherin functions in both Wnt-mediated and AKT-
mediated β-catenin transcriptional activation. Furthermore,
our findings suggest that N-cadherin mediated activation
of AKT signaling functions in cortical precursors in vivo to
promote β-catenin signaling, and inhibition of AKT leads
to reduced β-catenin signaling and premature exit from
the VZ, neuronal differentiation, and increased apoptosis
(Figure 8).The Cre-mediated N-cadherin knockout in developing
cortical precursors and the co-culture experiments pre-
sented provide two complementary lines of evidence sug-
gesting that reduction or interference with N-cadherin
reduces β-catenin signaling activity in a cell-autonomous
manner. Our findings with co-cultured signaling/responder
cells also suggest - but do not provide definitive evidence
for - a role for N-cadherin-dependent cell contact in Wnt-
signaling. Our observations of a small trend of reduced
Wnt-signaling when N-cadherin is reduced in Wnt-
producing cells are consistent with mechanisms where
cell-cell adhesion enhances Wnt signaling, potentially by
optimizing the physical interactions and/or proximity of
ligand and receptor. In vivo, our studies are also consistent
with a function for N-cadherin in physical retention of
neural precursors in the VZ. However, our findings that
cells still located in the VZ also show reduced β-catenin
signaling (Figures 1B and Figure 7 [4]) suggest that the
model that N-cadherin maintenance of β-catenin occurs
solely via physical retention of cells in the VZ is likely
overly simplistic. We find that when N-cadherin or αE-
catenin (another critical component of the VZ adherens
junction) [4] are reduced, we observe reductions in β-
Figure 6 AKT prevents premature differentiation of neural progenitors in vivo. (A) E13.5 forebrains were electroporated in utero with
pCAG-GFP and 4-fold (by mass) excess of pcDNA control or K197M dominant negative AKT (DN-AKT) and analyzed at E14.5 (n = 4 brains each).
Electroporated cells were identified using antibody staining against GFP and sections counterstained with DAPI. The pial surface is indicated by
the white line. Scale bar = 100 μm. (B) To quantify changes in cortical positioning of electroporated cells, ten equal sized bins were drawn over
each image covering the cortical plate. Each dot corresponds with the soma of an electroporated cell. The fraction of the total GFP + cells was
then graphed. The x-axis denotes the fraction of the total number of electroporated cells in each bin. Brackets indicate 1 SEM. (C-F) Sections of
electroporated brains were stained for Pax6 (C), Tbr2 (D), and Tbr1 (E). Electroporated cells are green, and the respective antigens are red.
Bar = 100 μm. The dot plots show the electroporated cells co-expressing the marker as yellow and electroporated cells not expressing the marker
as green. (F) Cell histograms show the fraction of electroporated cells that express each marker after electroporation (yellow/yellow + green dots).
DN-AKT causes premature neuronal differentiation as defined by the alterations in Tbr1, Tbr2, and Pax6 expression. For Pax 6, DN-AKT versus
control (n = 4 brains for each, **P = 0.0071), Tbr2 (n = 2 for DN-AKT, n = 4 for pcDNA control, *P = 0.0406), and Tbr1 (n = 4 for each, *P = 0.0277),
unpaired t-test. Error bars represents SEM. Scale bar = 100 μm. (G) DN-AKT increases the fraction of cells that lose contact with ventricular surface.
n = 4 brains, *P = 0.0368, paired t-test. Error bar represents SEM. EP’d, electroporated.
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Figure 7 Dominant negative AKT increases apoptotic cell death in vivo. E13.5 forebrains were electroporated in utero with pCAG-GFP and
4-fold (by mass) excess of pcDNA control or K197M dominant negative AKT (DN-AKT) and analyzed at E14.5. Sections of electroporated brains
were stained for GFP, cleaved caspase 3, and DNA stained with DAPI. Arrows point to electroporated cells that are expressing cleaved caspase 3.
Bright red round spots are non-specific staining not associated with cells. Bar = 50 μm. Compared with control, electroporation of DN-AKT causes
increased cell death, P = 0.0067 by paired students t-test. n = 3 brains for each condition. EP’d, electroporated.
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electroporated cells that have not yet left the VZ still ex-
hibit reduced signaling.
Distinguishing between a purely adhesive versus signal-
ing role of N-cadherin is challenging; loss of N-cadherin
will cause breakdown of cell contacts and disruptions of
neuroepithelial adhesion [41,42], and the possibility re-
mains that adhesion and signaling function of N-cadherin
cannot be separated. It is well known that regulators of
cell polarity (such as scribble [43,44] and aPKC [45,46])
play a critical role in inhibiting neoplastic growth, and we
believe that N-cadherin maintenance of cell adhesion in
neural precursors may similarly link growth and polarity,
but via control of β-catenin signaling and adhesion in a
normal developmental context.
How cadherin adhesion can both negatively and posi-
tively regulate β-catenin signaling activity remains poorly
understood. Observations that the forced overexpression
of cadherins antagonizes β-catenin transcriptional activa-
tion suggested the simple model that cadherins set a thresh-
old for β-catenin signaling. However, our findings suggest
that N-cadherin functions both in Wnt-mediated activation
of β-catenin via phosphorylation of the Wnt co-receptorLRP6 and in activation of β-catenin via AKT-mediated
phosphorylation of Ser 552 of β-catenin. In contrast to the
widely held viewpoint that cadherins are considered nega-
tive regulators of β-catenin signaling through sequestration
[47], our findings lend additional support to a growing body
of studies suggesting a positive role for a classical cadherin
in β-catenin signaling [28,48-51].
Our findings that N-cadherin functions to positively
regulate Wnt-mediated β-catenin signaling through the
Wnt co-receptor LRP6 support a recent study showing
that Casein kinase 1 (CK1) association with LRP5/6 re-
quires cadherin [51]. p120 catenin, via interactions with
cadherin and CK1, appears to control assembly of the
Wnt signaling complex [50]. As phosphorylation of
LRP6 by CK1 isoforms plays an essential function in
Wnt receptor complex activation [52], these findings to-
gether support a positive role for cadherin in Wnt/β-
catenin signaling.
While Wnt-mediated β-catenin signaling in cortical
development has been suggested by LRP6 mutant mice
[53] and Wnt overexpression studies [54], the role of
alternative regulation of β-catenin signaling in cortical
development is not well investigated. Here, our
Figure 8 Model for the function of N-cadherin in β-catenin activation and cortical development. (A) N-cadherin functions in the activation
of β-catenin signaling via AKT-mediated phosphorylation of β-catenin and Wnt-mediated activation of the Wnt co-receptor, LRP6. In
Wnt-mediated signaling, N-cadherin is required in a cell-autonomous manner in the responding cell and is involved in signaling via
phosphorylation of the Wnt co-receptor LRP6. N-cadherin also functions to stimulate β-catenin signaling via AKT activation and subsequent
phosphorylation of β-catenin at Ser 552. (B) In cortical radial glial neural progenitors, N-cadherin regulates epithelial integrity, and enhances
Wnt-mediated and AKT-mediated β-catenin activation. Downstream of N-cadherin, AKT signaling functions to promote self-renewal via activation
of β-catenin signaling as well as inhibiting apoptosis.
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ing in cortical precursors in vivo, and inhibition of
AKT activity leads to premature neuronal differenti-
ation and exit from the VZ. Consistent with previously
reported functions of AKT signaling in cell survival,
we also observed that inhibition of AKT in vivo by
electroporation leads to increased apoptotic cell death.
The alterations we observe in the proportions of cells
that are progenitors or differentiated neurons after AKT
inhibition may be a consequence of increased cell death
in progenitor populations. However, it is difficult toextrapolate the effects of increased progenitor cell death
on cells that differentiate from the progenitors, as their
number would also be reduced as a consequence of pro-
genitor death. Our findings of a relative increase in Tbr1
and Tbr2-expressing cells as well as increased migratory
distance following DN-AKT supports a role in differenti-
ation versus an exclusive role in cell survival.
Our results support recent findings that AKT and
PI3K signaling functions in cortical growth, with gain-
of-function mutations implicated in human HMG
[8-10], and suggest that abnormal activation of β-
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nisms driving cortical overgrowth in HMG.Conclusions
Here, we provide evidence that cell-autonomous N-
cadherin co-ordinates both Wnt-dependent and AKT-
mediated β-catenin activation. In the presence of Wnt,
N-cadherin regulates LRP6 phosphorylation, while when
Wnt is absent, N-cadherin also regulates β-catenin tran-
scriptional activation via AKT-mediated phosphorylation
of β-catenin Ser 552. Using in utero electroporation
approaches, we found evidence that AKT regulates β-
catenin signaling levels in VZ cortical precursors, and
loss of function experiments showed that inhibition of
AKT signaling causes increased apoptosis, premature
neuronal differentiation, and exit from the VZ. Our find-
ings that AKT functions in cortical precursors support
the observations of recent studies suggesting a role for
AKT in human megalenecephaly.Methods
Animals
All mice in this study were treated according to pro-
tocols reviewed and approved by the institutional animal
care and use committees of Northwestern University,
Animal Study Protocol # 2010–1863, approved by the
Northwestern University Office for the Protection of Re-
search Subjects Institutional Animal Care and Use Com-
mittee. Timed-pregnant C57BL/6 mice were ordered
from Charles River Laboratories (Wilmington, MA,
USA). NcadFlox/Flox mice (B6.129S6(SJL)-Cdh2tm1Glr/J) and
Nes-Cre (B6.Cg-Tg(Nes-cre)1Kln/J) mice were obtained
from The Jackson Laboratory (Bar Harbor, ME, USA).
NcadFlox/Flox mice were genotyped using primers 5′-TG
CTGGTAGCATTCCTATGG-3′ and 5′-TACAAGTTTG
GGTGACAAGC-3′ as previously described [21]. Nes-Cre
mice were genotyped according to The Jackson Laboratory
protocols available at http://jaxmice.jax.org/protocolsdb/f?
p=116:2:903366808665603::NO:2:
P2_MASTER_PROTOCOL_ID,P2_JRS_CODE:288,003771
(Cre). Axin2-d2EGFP reporter mice [19] (a gift from F
Costantini, Columbia University Medical Center, New York,
NY, USA) have been used to report β-catenin signaling
in vivo [20]. Axin2-d2EGFP reporter mice were genotyped
as described [19].
Axin2-d2EGFP and Nes-Cre mice were mated to
NcadFlox/Flox mice to generate (Axin2-d2EGFP; NcadFlox/+)
and (NesCre; NcadFlox/+) F1 progenies, respectively. (Axin2-
d2EGFP; NcadFlox/+) and (NesCre; NcadFlox/+) F1 progenies
were mated to generate E12.0 embryos of (Axin2-d2EGFP;
NesCre; NcadFlox/Flox) genotype. Littermate embryos of
(Axin2-d2EGFP; NesCre; NcadFlox/+) and (Axin2-d2EGFP;
NcadFlox/Flox) genotypes were used as controls without N-cadherin conditional knockout. Embryos were harvested
at E12.0.
Plasmids
pSUPER.retro.puro driving shRNAs against N-cadherin
(GACTGGATTTCCTGAAGAT; nucleotides 431–449 of
mouse N-cadherin [GenBank:AB008811], which is iden-
tical to nucleotides 215–233 of human N-cadherin [Gen
Bank:BC036470]) and control EGFP (CGATGCCACC
TACGGCAAG; nucleotides 786–804 of GFP [GenBank:
U55762]) were generously provided by M Wheelock
(University of Nebraska, Lincoln, NE, USA). The shRNA
to EGFP was used as the control for the Ncad-shRNA
construct. pcDNA-Myr-AKT and DN-AKT (K197M)
were kindly provided by Anna Kenney (Memorial Sloan
Kettering cancer center 1275 York Ave., New York City,
NY USA). The shRNA to eGFP was used as the control
for the pSUPER Ncad-shRNA construct. Similar pheno-
types were obtained with a second shRNA construct
targeting mouse N-cadherin; mouse shRNAmir to N-
cadherin in pSHAG-MAGIC 2c (pSM2c) retroviral vector
was obtained from Open Biosystems (Thermo Scientific;
81 Wyman St. Waltham, MA 02454), accession number
NM_007664, with oligonucleotide ID: V2MM_13176, tar-
get sequence: GCAGGCAAAGTTCCTGATATA. Control
non-silencing shRNA (cat. RHS1703) is a negative control
that expresses sequence TCTCGCTTGGGCGAGAGTA
AG which has no homology to known mammalian genes.
This non-silencing construct was used as a control to the
two shRNAmir constructs.
In utero electroporation
For in utero injection, timed-pregnant mice at E13.5
were anesthetized using inhalation of isoflurane mixed
in a constant ratio with oxygen, after which abdominal
fur was removed, and the uterine horns were exposed
through a midline laparotomy incision. DNA solution
(2.5 μL) in H2O containing 0.0125% fast green was
injected through the uterine wall into the lateral ven-
tricle of the embryos using a glass micropipette made
from a microcapillary tube. After injection, Tweezer-trodes
(BTX, 84 October Hill Rd. Holliston, MA 01746–1388)
were applied across the outside of the uterus, oriented to
flank the embryonic brain, and five 50 ms square pulses of
39 V with 950 ms intervals were delivered by an elec-
troporator (BTX 830). Following injection and electropo-
ration, the uterus is returned inside the abdomen and the
abdominal muscle wall and skin sealed with sutures.
To study the effect of N-cadherin knockdown on TOP-
dGFP signaling in vivo, 0.8 μg/μL of DNA was used for
pcDNA-Cre, pcDNA-lacZ, pCAG-mCherry and TOP-
dGFP. To study the effect of DN-AKT on TOP-dGFP sig-
naling in vivo, 0.25 μg/μl of pCAG-mCherry, 0.5 μg/μl of
TOP-dGFP, and 1.0 μg/μl of DN-AKT or pcDNA3.0 were
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of DNA for pCAG-GFP and 0.75 μg/μl of DN-AKT or
pcDNA3.0 were used.
For the TOP-dGFP signaling studies, embryos were
sacrificed 30 hours after electroporation. For the distribu-
tion and differentiation studies, embryos were sacrificed
24 hours after electroporation. Brains were fixed for 8 to
16 hours in 4% paraformaldehyde, cryoprotected in 30%
sucrose dissolved in PBS overnight, and embedded in
OCT (Optimal Cutting Temperature compound). A cryo-
stat was used to make 12 μm coronal sections.
For studies of TOPdGFP expression in NcadFlox/Flox
mice, histograms in Figure 1B were derived from three
brains, 312 cells (mCherry, pcDNA-lacZ control), and
three brains, 261 cells (mCherry, pcDNA-Cre). To deter-
mine the effect of DN-AKT on TOPdGFP in C57/B6
mice, three brains, 522 cells (mCherry, DN-AKT), and
three brains, 645 cells (mCherry, pcDNA3.0 control),
were analyzed. Cell distribution histograms were derived
from four brains (GFP, DN-AKT), 706 cells, and four
control brains (GFP, pcDNA3.0), 540 cells.
For studies of cell identity, histograms of Pax6, Tbr2 and
Tbr1 expressing cells were derived from four brains, 690
GFP + cells (Pax6, DN-AKT), four brains, 1099 GFP +
cells (Pax6, pcDNA3.0); two brains, 227 GFP + cells (Tbr2,
DN-AKT), four brains, 489 GFP + cells (Tbr2, pcDNA3.0);
four brains, 652 GFP + cells (Tbr1, DN-AKT), and four
brains, 1092 GFP + cells (Tbr1, pcDNA3.0).
Immunohistochemistry and tissue analysis
Brain sections were incubated with blocking solution
(5% goat serum and 0.3% Triton X-100 in PBS) for
1 hour at room temperature, and then incubated with
primary antibodies diluted in blocking solution for 2
hours at room temperature (for Pax6, Tbr2, Tbr1,
mCherry and TOPdGFP) or overnight at 4°C (for Axin2-
d2EGFP, phospho-AKT, phospho-GSK3β, phospho-β-
catenin, phospho-Vimentin 4A4, and GFP in distribu-
tion assay). Primary antibodies used were anti-GFP
chicken polyclonal antibody (1:1000, Abcam, 1 Kendall Sq,
Cambridge, MA 02139), anti-N-cadherin mouse monoclo-
nal antibody (1:1000, BD Transduction LaboratorieBD
Biosciences 2350 Qume Drive San Jose, CA 95131), anti-
DsRed (mCherry) rabbit polyclonal antibody (1:1000,
Clontech 1290 Terra Bella Ave. Mountain View, CA 94043
USA), anti-Pax6 mouse monoclonal antibody (1:200, De-
velopmental Studies Hybridoma University of Iowa, De-
partment of Biology 028 Biology Building East Iowa City,
Iowa 52242–1324), anti-Tbr2 rabbit polyclonal antibody
(1:250, Abcam), anti-Tbr1 rabbit polyclonal antibody
(1:200, Chemicon EMD Millipore Headquarters 290 Con-
cord Road Billerica, MA 01821), anti-phospho-AKT Ser
473 D9E rabbit monoclonal antibody (1:50, Cell Signaling
3 Trask Lane Danvers, MA 01923), anti-phospho-GSK3βSer 9 rabbit polycolonal antibody (1:100, Cell Signaling),
and anti-phospho-β-catenin Ser 552 rabbit antibody (1:250,
kindly provided by Mark Hembree and Linheng Li, Stowers
Institute 1000 E 50th St, Kansas City, MO 64110 U). After
washing in PBS, the sections were then incubated with
secondary antibodies and DAPI diluted in PBS for 1 hour
at room temperature. Secondary antibodies used were
Alexa488-conjugated goat anti-chicken IgG antibody
(1:1000, Molecular Probes Life Technologies 3175 Staley
RoadGrand Island, NY 14072 USA), Alexa555-conjugated
goat anti-mouse IgG antibody (1:1000; Molecular Probes),
Alexa555-conjugated goat anti-rabbit IgG antibody (1:1000;
Molecular Probes), Alexa647-conjugated goat anti-mouse
IgG antibody (1:1000; Molecular Probes), Alexa647-
conjugated goat anti-rabbit IgG antibody (1:1000; Molecu-
lar Probes), and Alexa488-conjugated goat anti-mouse IgG
antibody (1:1000; Molecular Probes). Finally, immunofluor-
escent images of the (Ax2GFP; NesCre; NcadFlox/Flox) brains
and controls were captured using a Nikon ECLIPSE
TE2000-U fluorescent microscope (Nikon Inc. 1300 Walt
Whitman Road Melville, NY 11747–3064, U.S.A.). Confocal
images were captured using a Zeiss UV LSM510 confocal
microscope Carl Zeiss Microscopy, LLC One Zeiss Drive
Thornwood, NY 10594 USA). The analysis throughout the
paper was carried out in a semi-blinded manner as previ-
ously described [3].Primary neural stem cell culture, shRNA, and treatment
with function-blocking antibodies
For Western blots of N-cadherin, phospho-β-catenin S552,
β-catenin, phospho-Akt S473 and Akt, E14.5 mouse pri-
mary cortical cultures were generated from E14.5 mouse
embryos using minor modifications to the method de-
scribed in [55]. After dissection, cells were disassociated
with 0.25% Trypsin/EDTA (Sigma), washed by DMEM with
10% FBS, and resuspended in clone density media (CDM)
containing DMEM (Cellgro Mediatech, Inc. 9345 Discovery
Blvd. Manassas, VA 20109), 2 mM L-glutamine (Cellgro),
1 mM N-Acetyl-cysteine, 1 mM sodium pyruvate, and
B27 and N2 supplement (final 1×) with 25 ng/mL FGF-2.
Five million primary cortical precursors were transfected
with 10 μg shRNA constructs against N-cadherin or EGFP
control using Nucleofector following the manufacture’s
protocol (Lonza Lonza Inc. 90 Boroline Road Allendale,
NJ 07401). Transfected cells were plated on Poly-D Lysine
treated 6-well tissue culture plates and allowed to recover
in the described media (as above) at 37°C for 24 hours
before lysing for Western blots. Adherent cortical NSC
cultures were generated from E14.5 mouse embryos as
described in [30,31]. After dissection, cells were dissociated
with Accutase (Millipore EMD Millipore Headquarters
290 Concord Road Billerica, MA 01821), washed three
times with NS-A medium (Stem Cell Technologies #5750
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Suite 400, Vancouver, BC, V5Z 1B3, Canada), rinsed once
more with NSC medium (NS-A supplemented with FGF-2,
EGF, N-2A, B27, L-glutamine, Sodium pyruvate, N-acetyl
cysteine, and Penicillin-streptomycin as in [31]) and plated
on laminin-coated (treated with 2 μg/cm2 laminin) dishes.
To obtain material for protein analysis, 5 million mouse
E13.5 or E14.5 primary cortical precursors was transfected
by AMAXA Nucleofection (Amaxa Biosystems, Gaithers-
burg, MD, USA) following manufacturer protocols; cells
were allowed to recover in the described media (as above)
at 37°C for 24 hours before lysing for Western blots.
Cells were plated at 1.8 × 105/cm2 for 24 hours, then
treated with either function-blocking N-cadherin antibody
(ACAM, GC-4, Sigma) or control IgG1κ isotype control
(BD Pharmingen cat. 554721 BD Biosciences 2350 Qume
Drive San Jose, CA 95131) (both at 20 μg/ml, final concen-
tration) for 24 hours.
293 T co-culture and luciferase assays
293 T cells were maintained in cDMEM media containing
DMEM (Cellgro), 10% FBS, 2 mM L-glutamine (Cellgro)
and Penicillin:streptomycin (Cellgro). For transwell co-
culture assays, signaler and reporter cells were transfected
separately on day 1 and plated together after 24 hours. On
day 1, signaler cells (1 × 106 293 T cells) were transfected
with 1.0 μg Wnt or pcDNA3.0 control using Lipofectamine
2000 following the manufacturer’s protocol (Life Techno-
logies Life Technologies 3175 Staley RoadGrand Island,
NY 14072 USA) and plated in a 24-well plate. Reporter
cells (5 × 105 293 T cells) were transfected with 1.0 μg
Super8xTOP FLASH Luciferase and 0.1 μg Super8xFOP
Renilla using Lipofectamine 2000, and plated either (1)
on the outside of the 6.5 mm transwell membrane inserts
with 0.4 μm pore size (Costar Corning Incorporated
Life Sciences 836 North Street Building 300 Suite 3401
Tewksbury, MA 01876, USA) inverted in a 6-well plate
or (2) on the bottom of a 12-well plate. After 24 hours, the
6.5 mm transwell membrane inserts with reporter cells
attached were inverted and placed in a 12-well plate soaked
in media. Signaler cells in the 24-well plate were lifted by
0.25% Trypsin/EDTA and one-quarter of the cells were
plated on the inside of the transwell membrane inserts
(“Membrane-bound” condition). The pore size of these in-
serts is 0.4 μm, through which cells plated on opposite
sides of the insert can establish physical contacts [26,27].
For the “Separated” condition, the signaler cells were plated
inside transwell membrane inserts and placed above the
12-well plate with the reporter cells plated on the bottom
of the well [26]. After incubated for 24 hours at 37°C, the
reporter cells were lysed for Dual luciferase assay (Dual-
LuciferaseW Reporter Assay System, Promega Promega
Corporation 2800 Woods Hollow Road Madison, WI
53711 USA).For 293 T co-culture with N-cadherin knockdown, the
reporter and signaler cells were generated similarly to
that described above (1 × 106 cells were transfected by
1.0 μg Super8xTOP FLASH Luciferase and 0.1 μg Super8x-
FOP Renilla as reporter cells, and a further 1 × 106 cells
were transfected by 1.0 μg Wnt3a or pcDNA3.0 control as
signaler cells), with the difference that 0.25 μg N-cadherin/
EGFP-shRNA (or NCAD-ΔC/pIRES-GFP control) were
transfected into either the reporter or signaler cells; pc-
DNA3.0 empty vector was used to bring the total DNA
mass to 1.6 μg in all the transfections. After 24 hours, the
reporter and signaler cells were lifted by 0.25% Trypsin/
EDTA, and one-half of the signaler cells and one-sixth of
the reporter cells were mixed and plated on a 24-well plate.
The cells were lysed after another 48 hours for Dual lucifer-
ase assay.
293 T transfection
To collect the protein lysates for N-cadherin knockdown
studies, 293 T cells were transiently transfected using
Lipofectamine 2000 following the manufacturer’s proto-
col (Life Technologies). 293 T cells (1 × 106) were plated
on a 12-well tissue culture plate and transfected by 1.2 μg
Wnt or pcDNA3.0 control together with 2.0 μg N-
cadherin or EGFP shRNA construct. Cells were allowed to
recover in cDMEM at 37°C for 24 hours before lysing for
Western blots. For AKT studies, 1 × 106 293 T cells were
plated on a 24-well tissue culture plate and immediately
transfected by 1.0 μg HA-AKT-K179M or pcDNA3.0
control.
Western blot analysis
To prepare whole cell lysates, 293 T cells or mouse NSC
lines were obtained as described above and collected in
RIPA lysis buffer (50 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 1% TritonX-100, 1% sodium deoxycholate, 0.1%
SDS) containing Protease Inhibitor Cocktail Set III
(Calbiochem EMD Millipore Headquarters 290 Concord
Road Billerica, MA 01821) and Phosphotase Inhibitor
Cocktail I (Sigma). Cells were passed through an insulin
syringe to shear and centrifuged at 14,000 rpm for 10
minutes at 4°C. Supernatants were collected and com-
bined with 4× SDS sample buffer and boiled for 5 to 10
minutes. The resulting protein samples were applied to
8% or 6% SDS-PAGE gel and transferred to PVDF mem-
branes. The blots were blocked with 5% milk/TBS-T or
5%BSA/TBS-T for 1 hour and probed with the following
primary antibodies: rabbit anti-phospho-LRP6 Ser 1490
(1:1000 dilution in 5% BSA; Cell Signaling), rabbit anti-
LRP6 (1:1000 dilution in 5% milk; Cell Signaling), mouse
anti-N-cadherin (1:1000 dilution in 5% milk; BD Trans-
duction Laboratories), rabbit anti-phospho-β-catenin Ser
552 (1:1000 dilution in 5% BSA; Cell Signaling), rabbit
anti-β-catenin (1:1000 dilution in 5% milk; Cell Signaling),
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BSA; Cell Signaling), rabbit anti-AKT (1:1000 dilution
in 5% milk; Cell Signaling), rabbit anti-phospho-GSK3β
Ser 9 (1:1000 in 5% BSA; Cell Signaling), rat (rabbit) anti-
GSK3β (1:500 dilution in 5% milk; Calbiochem), mouse
anti-actin (1:1000; dilution in 5% milk; Chemicon), and
rabbit anti-GAPDH (1:1000; dilution in 5% milk; Santa
Cruz Biotechnology Santa Cruz Biotechnology, Inc. 10410
Finnell Street Dallas, Texas 75220 U.S.A.). Blots were
washed × 3 with TBS-T before incubation with HRP-
conjugated goat anti-mouse antibody (1: 3000 dilution
in 5% milk, Bio-Rad 2000 Alfred Nobel Drive, Hercules,
CA 94547) or HRP-conjugated goat anti-rabbit antibody
(1: 5000 dilution in 5% milk, Bio-Rad) for 1 hour at room
temperature. The signal was visualized using the ECL
Western blotting system (Amersham GE Healthcare Bio-
sciences P.O. Box 643065 Pittsburgh, PA 15264–3065). To
ensure equal loading, protein concentrations were deter-
mined using the BCA Protein Assay (Pierce Thermo Scien-
tific; 81 Wyman St. Waltham, MA 02454). Densitometry
of scanned films was performed with ImageJ.
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